Pharma Responds To Sandy’s Wrath With Delays
This article was originally published in The Pink Sheet Daily
As the East Coast braces for the impact of Hurricane Sandy, companies choose the safety of their employees over keeping financial releases on schedule.
You may also be interested in...
Commenters in favor of and opposed to new restrictions on combination hydrocodone products make strong cases, but without much new data.
While most of the East Coast of the U.S. continues to struggle with the aftereffects of Hurricane Sandy, pharmaceutical industry operations are back to normal and the companies are doing what they can to help out.
The future Abbott spin-off tapped the bond market for financing just days after Hurricane Sandy brought trading to a halt and hours before the U.S. faced a leadership decision.